
New Parkinson's Disease Gene Discovered - Medscape
Jul 17, 2024 · A new gene for early-onset Parkinson's disease has been identified, a discovery that experts believe will have important clinical implications in the not-too-distant future.
Examining the Fingernails When Evaluating Presenting Symptoms …
Nov 23, 2009 · If the lunula is absent, consider anemia or malnutrition (Figure 16). A pyramidal lunula might indicate excessive manicure or trauma (Figure 17). A pale blue lunula suggests …
Talking About Sex Remains the Elephant in the Room for GPs
Sep 22, 2025 · This pyramidal framework begins with obtaining the patient’s permission to raise sexual issues, builds awareness of knowledge gaps, moves to “specific suggestions” based on …
Progressive Supranuclear Palsy and Corticobasal Degeneration
This article discusses the similarities and differences between these disorders in clinical manifestations, neuroimaging and neuropathology and provides a perspective on possible …
Cytisinicline Improves Quit Rates in Smokers - Medscape
Sep 25, 2025 · Cytisinicline significantly increases quit rates in smokers with or without COPD while being safe and well tolerated.
Modern Specialist Training: Brainchild of a Cocaine Addict
Mar 24, 2025 · The pyramidal structure of his training program, the competitive selection of exceptional residents, and their heavy workload all helped to conceal Halsted’s drug …
Diabetes and Liver: Drives Disease and Worsens Outcomes
Sep 22, 2025 · Dr Priya Jaisinghani discusses how diabetes drives liver disease progression and worsens clinical outcomes.
Our Diet Is Our Destiny - Medscape
Sep 10, 2025 · Dr Wilkoff explains that diet, not lack of exercise or sleep, is responsible for high rates of obesity.
Psilocybin Safe, Effective for TRD: Phase 3 Data - Medscape
Jun 24, 2025 · A single dose of a synthetic form of psilocybin is safe and clinically meaningful in reducing treatment-resistant depression, topline results from a phase 3 trial suggest.
Oral GLP-1 Will ‘Change and Enhance’ Obesity Treatment
Sep 24, 2025 · The FDA will decide on whether to approve the first oral formulation of a GLP-1 (once-daily semaglutide 25 mg) for chronic weight management by the end of the year.